Results 201 to 210 of about 148,544 (297)
Through network pharmacology and molecular docking, it has been discovered that CA can target MAOB, among other proteins, to exert a therapeutic effect in IBS. In vivo, CA lowered visceral hypersensitivity, anxiety and depression‐like behaviors, and fecal water content, highlighting its therapeutic potential for IBS via anti‐inflammatory pathways ...
Qingyang Yu +4 more
wiley +1 more source
Identification of a novel THRB mutation causing thyroid hormone resistance syndrome. [PDF]
Yang J, Wang C, Quan L, Jiang S.
europepmc +1 more source
This evidence map of 63 studies (n = 6158) showed growth hormone therapy in children with growth hormone deficiency has neutral glucose effects, mixed lipid outcomes, potential benefits for bone mineral density, bone mineral content, and parathyroid hormone, but generally no impact on thyroid function, body composition, or body mass index.
Wei Wu +6 more
wiley +1 more source
Changing understanding of acromegaly epidemiology and early mortality risk.
Esposito D, Johannsson G.
europepmc +1 more source
Calcaneal quantitative ultrasound parameters strongly correlate with DXA measurements in patients with acromegaly. [PDF]
Campana C +11 more
europepmc +1 more source
Pediatric nasal skull base tumors present diagnostic and therapeutic challenges due to their deep location, nonspecific symptoms, and the narrow nasal cavity in children. Although artificial intelligence (AI) and digital medicine have advanced early diagnosis, multidisciplinary treatment, and prognosis, their application in these rare tumors remains ...
Xiuping Wu +5 more
wiley +1 more source
Current treatment landscape of acromegaly.
Castinetti F, Ioachimescu AG.
europepmc +1 more source
Ageing and pituitary neuroendocrine tumours (PitNETs): from bench to bedside. [PDF]
De Alcubierre D +6 more
europepmc +1 more source
Multipathway schematic of endocrine therapy–induced cancer‐related fatigue. Endocrine interventions trigger four interacting mechanisms—neuroendocrine dysregulation, systemic inflammation, energy‐metabolic failure, and psycho‐behavioral amplification—that culminate in the multidimensional CRF phenotype.
Jiajing Jiang +7 more
wiley +1 more source
The Real-World Endocrine Toxicity Profile of ICIs, VEGFR-TKIs, and Their Combination: Analysis of the FDA Adverse Event Reporting System (FAERS) Database. [PDF]
Marrano N +12 more
europepmc +1 more source

